Beltapharm SPA DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier

29 Aug 2025

// BIOSPACE

Pfizer, Moderna score updated COVID Vaccine Approvals From FDA

29 Aug 2025

// FIERCE PHARMA

Cantargia Granted Important US Patent for Nadunolimab

29 Aug 2025

// ACCESSWIRE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

Pharmaconex

Not Confirmed

Book a meeting

envelop Contact Supplier

REF. STANDARDS & IMPURITIES

1 Others

otherProducts
1 Others

INSPECTIONS & REGISTRATIONS

3 FDA, 1 EDQM, 1 GDUFA

inspections
3 FDA
1 EDQM
1 GDUFA

About

BELTAPHARM S.p.A. was started in 1982 by a team of entrepreneurs with experience in the pharmaceutical field. Its scope is the production by contract manufacturing of pharmaceuticals for human. These are produced in the commonest pharmaceutical forms, mainly as generics (ex galenics), for export outside Europe (Africa, Asia and Latin America). Beltapharm S.p.A is approved as third-party manufacturer by several Italian and European companies for the production of pharmaceuticals in liquid and semi-solid forms, with a particular emphasis on steroid-based products like: cream,ointments and gels, both for human and veterinary use.